These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16305548)

  • 1. Expressed protein ligation to obtain selectively modified aldo/keto reductases.
    Richter MP; Beck-Sickinger AG
    Protein Pept Lett; 2005 Nov; 12(8):777-81. PubMed ID: 16305548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative anatomy of the aldo-keto reductase superfamily.
    Jez JM; Bennett MJ; Schlegel BP; Lewis M; Penning TM
    Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):625-36. PubMed ID: 9307009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid sequence and characterization of aldo-keto reductase from bakers' yeast.
    Nakamura K; Kondo S; Kawai Y; Nakajima N; Ohno A
    Biosci Biotechnol Biochem; 1997 Feb; 61(2):375-7. PubMed ID: 9058981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression, purification, crystallization and preliminary X-ray analysis of perakine reductase, a new member of the aldo-keto reductase enzyme superfamily from higher plants.
    Rosenthal C; Mueller U; Panjikar S; Sun L; Ruppert M; Zhao Y; Stöckigt J
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Dec; 62(Pt 12):1286-9. PubMed ID: 17142919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The crystal structure of the GCY1 protein from S. cerevisiae suggests a divergent aldo-keto reductase catalytic mechanism.
    Hur E; Wilson DK
    Chem Biol Interact; 2001 Jan; 130-132(1-3):527-36. PubMed ID: 11306072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The xylose reductase (AKR2B5) structure: homology and divergence from other aldo-keto reductases and opportunities for protein engineering.
    Wilson DK; Kavanagh KL; Klimacek M; Nidetzky B
    Chem Biol Interact; 2003 Feb; 143-144():515-21. PubMed ID: 12604237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial aldo-keto reductases.
    Ellis EM
    FEMS Microbiol Lett; 2002 Nov; 216(2):123-31. PubMed ID: 12435492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalytic mechanism and substrate selectivity of aldo-keto reductases: insights from structure-function studies of Candida tenuis xylose reductase.
    Kratzer R; Wilson DK; Nidetzky B
    IUBMB Life; 2006 Sep; 58(9):499-507. PubMed ID: 17002977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.
    Barski OA; Tipparaju SM; Bhatnagar A
    Drug Metab Rev; 2008; 40(4):553-624. PubMed ID: 18949601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of a novel mouse liver aldo-keto reductase AKR7A5.
    Hinshelwood A; McGarvie G; Ellis E
    FEBS Lett; 2002 Jul; 523(1-3):213-8. PubMed ID: 12123834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in aldo-keto reductases immobilization for biocatalytic synthesis of chiral alcohols.
    Zhang W; Shao ZQ; Wang ZX; Ye YF; Li SF; Wang YJ
    Int J Biol Macromol; 2024 Aug; 274(Pt 1):133264. PubMed ID: 38901517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular evolution of the aldo-keto reductase gene superfamily.
    Seery LT; Nestor PV; FitzGerald GA
    J Mol Evol; 1998 Feb; 46(2):139-46. PubMed ID: 9452515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specifically immobilised aldo/keto reductase AKR1A1 shows a dramatic increase in activity relative to the randomly immobilised enzyme.
    Holland-Nell K; Beck-Sickinger AG
    Chembiochem; 2007 Jun; 8(9):1071-6. PubMed ID: 17508367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cloning, expression and catalytic activity of a human AKR7 member of the aldo-keto reductase superfamily: evidence that the major 2-carboxybenzaldehyde reductase from human liver is a homologue of rat aflatoxin B1-aldehyde reductase.
    Ireland LS; Harrison DJ; Neal GE; Hayes JD
    Biochem J; 1998 May; 332 ( Pt 1)(Pt 1):21-34. PubMed ID: 9576847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of two major forms of naloxone reductase from rabbit liver cytosol, new members of aldo-keto reductase superfamily.
    Yamano S; Ichinose F; Todaka T; Toki S
    Biol Pharm Bull; 1999 Oct; 22(10):1038-46. PubMed ID: 10549852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence and expression levels in human tissues of a new member of the aldo-keto reductase family.
    Hyndman DJ; Flynn TG
    Biochim Biophys Acta; 1998 Aug; 1399(2-3):198-202. PubMed ID: 9765596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a novel murine aldo-keto reductase.
    Bohren KM; Barski OA; Gabbay KH
    Adv Exp Med Biol; 1997; 414():455-64. PubMed ID: 9059651
    [No Abstract]   [Full Text] [Related]  

  • 18. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members.
    O'connor T; Ireland LS; Harrison DJ; Hayes JD
    Biochem J; 1999 Oct; 343 Pt 2(Pt 2):487-504. PubMed ID: 10510318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and properties of six aldo-keto reductases from rat adrenal gland.
    Inazu N; Nagashima Y; Satoh T; Fujii T
    J Biochem; 1994 May; 115(5):991-9. PubMed ID: 7961617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and biochemical analyses of YvgN and YtbE from Bacillus subtilis.
    Lei J; Zhou YF; Li LF; Su XD
    Protein Sci; 2009 Aug; 18(8):1792-800. PubMed ID: 19585557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.